Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities.

Wertman R, Altun E, Martin DR, Mitchell DG, Leyendecker JR, O'Malley RB, Parsons DJ, Fuller ER, Semelka RC. Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology. 2008 Sep; 248(3):799-806.

View in: PubMed